Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are effective and generally safe for treating alopecia areata, but monitoring for side effects is important.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Tirzepatide may improve hair loss by reducing insulin resistance.

Dupilumab may help regrow hair in people with severe alopecia.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Baricitinib improves alopecia areata and may help psoriasis but might not be ideal for psoriatic arthritis.

Pioglitazone may help treat lichen planopilaris, but more research is needed.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

Delonix polymeric nanoparticles with isotretinoin effectively treat acne by targeting hair follicles and reducing skin irritation.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

A young woman with lupus developed tuberculosis due to weakened immunity from her medication, showing the need for better TB screening in such patients.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Two children with lysinuric protein intolerance showed symptoms similar to lupus.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

The 2012 SLICC criteria provide an updated method for classifying Systemic Lupus Erythematosus.

Dupilumab helps children with alopecia areata regrow hair safely.

The treatment was effective for lupus nephritis with manageable side effects.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Effective management of side effects is crucial for safe use of sacituzumab govitecan in advanced breast cancer treatment.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.